NFKB1 and neoplasm: Specifically, DCA drives reactive oxygen species (ROS) production and activates activator protein-1 (AP-1), NF-κB, and cyclooxygenase-2 (COX-2) pathways in colonic epithelial cells, while in cancer cells it further induces DNA damage and mutation accumulation, thereby accelerating tumor progression (38).